How to treat hormone receptor-positive, human epidermal growth factor receptor 2-amplified breast cancer

MeSH terms

• Anastrozole
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents, Hormonal / administration & dosage*
• Antineoplastic Agents, Hormonal / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Biomarkers, Tumor / analysis
• Biomarkers, Tumor / genetics
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / genetics
• Breast Neoplasms / mortality
• Disease-Free Survival
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Female
• Humans
• Lapatinib
• Nitriles / administration & dosage
• Nitriles / adverse effects
• Prognosis
• Quinazolines / adverse effects
• Quinazolines / therapeutic use
• Randomized Controlled Trials as Topic
• Receptor, ErbB-2 / genetics
• Receptor, ErbB-2 / metabolism*
• Receptors, Estrogen / genetics
• Receptors, Estrogen / metabolism*
• Risk Assessment
• Survival Analysis
• Time Factors
• Trastuzumab
• Triazoles / administration & dosage
• Triazoles / adverse effects